HI
BPMC

Handelsinvest Investeringsforvaltning’s Blueprint Medicines BPMC Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$368K Sell
3,876
-2,012
-34% -$173K 0.18% 120
2023
Q4 		$543K Buy
+5,888
New +$382K 0.22% 117

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's BPMC Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Blueprint Medicines (BPMC) stake by 34% in Q1 2024, selling an estimated $173K and leaving 3,876 shares worth $368K. The position accounts for 0.18% of the portfolio, ranked #120.

Handelsinvest Investeringsforvaltning first reported a position in BPMC in Q4 2023 and has held it in 2 quarters since. The position peaked at $543K in Q4 2023. 283 funds tracked by Wall St. Rank hold BPMC as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 3,876 shares of Blueprint Medicines worth $368K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 2,012 Blueprint Medicines shares in Q1 2024, an estimated $173K.
  • Blueprint Medicines made up 0.18% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #120 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Blueprint Medicines in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Blueprint Medicines position peaked at $543K in Q4 2023.
  • 283 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.